These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19216007)

  • 1. Preparation of spermine conjugates with acidic retinoids with potent ribonuclease P inhibitory activity.
    Magoulas G; Papaioannou D; Papadimou E; Drainas D
    Eur J Med Chem; 2009 Jun; 44(6):2689-95. PubMed ID: 19216007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of ribonuclease P activity from human epidermis and its regulation by retinoids in vitro.
    Pavlidou D; Vourekas A; Monastirli A; Kalavrizioti D; Tsambaos D; Drainas D
    Acta Derm Venereol; 2006; 86(2):114-8. PubMed ID: 16648912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoids inhibit human epidermal keratinocyte RNase P activity.
    Papadimou E; Pavlidou D; Séraphin B; Tsambaos D; Drainas D
    Biol Chem; 2003 Mar; 384(3):457-62. PubMed ID: 12715896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase.
    Minkkilä A; Saario SM; Käsnänen H; Leppänen J; Poso A; Nevalainen T
    J Med Chem; 2008 Nov; 51(22):7057-60. PubMed ID: 18983140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and aldose reductase inhibitory activities of novel O-substituted hydroxyphenylacetic acid derivatives.
    Rakowitz D; Angerer H; Matuszczak B
    Arch Pharm (Weinheim); 2006 Oct; 339(10):547-58. PubMed ID: 17009299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based optimization of a potent class of arylamide FMS inhibitors.
    Meegalla SK; Wall MJ; Chen J; Wilson KJ; Ballentine SK; Desjarlais RL; Schubert C; Crysler CS; Chen Y; Molloy CJ; Chaikin MA; Manthey CL; Player MR; Tomczuk BE; Illig CR
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3632-7. PubMed ID: 18495479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial purification and characterization of RNase P from human peripheral lymphocytes.
    Vourekas A; Vryzaki E; Toumpeki C; Stamatopoulou V; Monastirli A; Tsambaos D; Drainas D
    Exp Dermatol; 2009 Feb; 18(2):130-3. PubMed ID: 18637127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of novel pyrrolidine 3,4-diol derivatives as inhibitors of alpha-L-fucosidases.
    Moreno-Clavijo E; Carmona AT; Vera-Ayoso Y; Moreno-Vargas AJ; Bello C; Vogel P; Robina I
    Org Biomol Chem; 2009 Mar; 7(6):1192-202. PubMed ID: 19262940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorogenic acid derivatives with alkyl chains of different lengths and orientations: potent alpha-glucosidase inhibitors.
    Ma CM; Hattori M; Daneshtalab M; Wang L
    J Med Chem; 2008 Oct; 51(19):6188-94. PubMed ID: 18783210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of arotinoids on tRNA biogenesis.
    Papadimou E; Monastirli A; Tsambaos D; Merk HF; Drainas D
    Skin Pharmacol Appl Skin Physiol; 2000; 13(6):345-51. PubMed ID: 11096376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New cyclopentane derivatives as inhibitors of steroid metabolizing enzymes AKR1C1 and AKR1C3.
    Stefane B; Brozic P; Vehovc M; Rizner TL; Gobec S
    Eur J Med Chem; 2009 Jun; 44(6):2563-71. PubMed ID: 19237229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial RNase P as a potential target for novel anti-infectives.
    Eder PS; Hatfield C; Vioque A; Gopalan V
    Curr Opin Investig Drugs; 2003 Aug; 4(8):937-43. PubMed ID: 14508877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingolactones: selective and irreversible inhibitors of neutral sphingomyelinase.
    Wascholowski V; Giannis A
    Angew Chem Int Ed Engl; 2006 Jan; 45(5):827-30. PubMed ID: 16365835
    [No Abstract]   [Full Text] [Related]  

  • 14. Design and preparation of potent, nonpeptidic, bioavailable renin inhibitors.
    Bezençon O; Bur D; Weller T; Richard-Bildstein S; Remen L; Sifferlen T; Corminboeuf O; Grisostomi C; Boss C; Prade L; Delahaye S; Treiber A; Strickner P; Binkert C; Hess P; Steiner B; Fischli W
    J Med Chem; 2009 Jun; 52(12):3689-702. PubMed ID: 19358611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel lipophilic inhibitors of OXA-10 enzyme (class D beta-lactamase) by screening amino analogs and homologs of citrate and isocitrate.
    Beck J; Vercheval L; Bebrone C; Herteg-Fernea A; Lassaux P; Marchand-Brynaert J
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3593-7. PubMed ID: 19467869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effects in gene delivery-a structure-activity approach to the optimisation of hybrid dendritic-lipidic transfection agents.
    Jones SP; Gabrielson NP; Pack DW; Smith DK
    Chem Commun (Camb); 2008 Oct; (39):4700-2. PubMed ID: 18830464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial RNase P RNA is a drug target for aminoglycoside-arginine conjugates.
    Berchanski A; Lapidot A
    Bioconjug Chem; 2008 Sep; 19(9):1896-906. PubMed ID: 18712898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MMT, Npeoc-protected spermine, a valuable synthon for the solid phase synthesis of oligonucleotide oligospermine conjugates via guanidine linkers.
    Perche P; Kotera M; Remy JS
    Bioorg Med Chem; 2011 Mar; 19(6):1972-7. PubMed ID: 21339069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, biological evaluation, and structure-activity relationship (SAR) discussion of dipeptidyl boronate proteasome inhibitors, part I: comprehensive understanding of the SAR of alpha-amino acid boronates.
    Zhu Y; Zhao X; Zhu X; Wu G; Li Y; Ma Y; Yuan Y; Yang J; Hu Y; Ai L; Gao Q
    J Med Chem; 2009 Jul; 52(14):4192-9. PubMed ID: 19537716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of substituted pyrazolo[1,5-a]quinazolin-5(4H)-one as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors.
    Orvieto F; Branca D; Giomini C; Jones P; Koch U; Ontoria JM; Palumbi MC; Rowley M; Toniatti C; Muraglia E
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4196-200. PubMed ID: 19541484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.